Table 3 Detailed characteristics of patients who underwent pancreatic surgery
| Â | ID | Age [years] | ASA-Score | Sex | Radiological diagnosis | HRS at diagnosis | WF at diagnosis | Time from diagnosis [months] | Indication for surgery | Procedure* | Postoperative histopathological diagnosis |
|---|---|---|---|---|---|---|---|---|---|---|---|
Primary surgery | #1 | 72 | 2 | M | MT, head, cyst 10 mm, MPD 5 mm | − |  +  | 13 | WF at diagnosis (recurrent pancreatitis + MPD dilatation) | DP | MT-IPMN, 20 mm, gastric type, moderate dysplasia |
#2 | 65 | 2 | F | BD, head/neck, cyst 55 mm | − |  +  | 3 | WF at diagnosis (cyst size + enhancing cyst walls) | PD | MT-IPMN, 46 mm, gastric type with PDAC pT1a (2 mm) pN0 (0/14) LV0 Pn0 R0 | |
#3 | 61 | 2 | F | MT, tail, cyst 16 mm, MPD 6 mm | − |  +  | 9 | WF at diagnosis (MPD dilatation) | DP | BD-IPMN, 20 mm, gastric type, low-grade dysplasia | |
#4 | 78 | 3 | M | MD, tail, cyst 30 mm | − |  +  | 7 | WF at diagnosis (recurrent pancreatitis + cyst size) | DP | MD-IPMN, type unknown,low-grade dysplasia | |
#5 | 71 | 2 | M | BD, head, cyst 13 mm |  +  |  +  | 2 | HRS at diagnosis (HGD at EUS-FNA) | PD | BD-IPMN, 14 mm, gastric type, low-grade dysplasia | |
#6 | 51 | 2 | M | BD, uncinate process, cyst 18 mm |  +  |  +  | 3 | HRS at diagnosis (HGD at EUS-FNA) | PD | BD-IPMN, 18 mm, gastric type, low-grade dysplasia | |
#7 | 65 | 2 | F | MT, head, cyst 28 mm, MPD 6 mm | − |  +  | 1 | HRS at diagnosis (MPD dilatation) | PD | MT-IPMN, 20 mm, gastric type, moderate dysplasia | |
#8 | 75 | 2 | M | MD, head, cyst 29 mm |  +  |  +  | 1 | HRS at diagnosis (obstructive jaundice + cyst size) | TP | MT-IPMN, gastric type with PDAC pT3 (38 mm) pN1 (3/18) LV0 pN1 R0 | |
#9 | 71 | 2 | M | BD, tail, cyst 12 mm | − | − | 3 | Concomitant NET of the pancreatic tail | DP | BD-IPMN, 15 mm, gastric type, no dysplasia (NET, 6 mm, G1) | |
#10 | 53 | 2 | F | BD, tail, cyst 14 mm | − | − | 2 | Elevated cyst CEA (suspicion mucinous cystadenoma) | DP | BD-IPMN, 14 mm, type unknown, low-grade dysplasia | |
Surveillance program | #11 | 50 | 3 | M | MT, head, cyst 84 mm, MPD 8 mm | − |  +  | 23 | Progression (cyst size 100 mm, rapid cyst growth) | PD | MT-IPMN, 100 mm, oncycytic type withhigh-grade dysplasia |
#12 | 63 | 3 | M | MD, head, cyst 19 mm, MPD 6 mm | − |  +  | 19 | Progression (rapid cyst growth) | PD | MD-IPMN, intestinal type high-grade dysplasia | |
#13 | 56 | 2 | M | BD, uncinate process, cyst 20 mm | − | − | 10 | Progression (cyst size 30 mm, rapid cyst growth) | PD | BD-IPMN, gastric type low-grade dysplasia | |
#14 | 67 | 2 | F | BD, neck/body, cyst 26 mm | − | − | 45 | Concomitant serous cystadenoma | PD | BD-IPMN, 15 mm, pancreatico-biliary type, low-grade dysplasia (serous cystadenoma, 11 mm) | |
#15 | 64 | 3 | M | BD, tail, cyst 17 mm | − | − | 15 | Concomitant gastric GIST | DP + gastric resection | BD-IPMN, 20 mm, gastric type, low-grade dysplasia (gastric GIST, 35 mm) |